A Three-miRNA-Based Expression Signature at Diagnosis Can Predict Occurrence of Relapse in Children With T(8;21) RUNX1 -RUNX1T1 Acute Myeloid Leukaemia

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14950
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

A Minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 Contributes to Leukemogenesis in T(8;21) Acute Myeloid Leukemia

International Journal of Cancer
Cancer ResearchOncology
2016English

Isolated CNS Leukaemic Relapse in Acute Myeloid Leukaemia

BMJ Case Reports
Medicine
2019English

Identification of a Novel RUNX1-TACC1 Fusion Transcript in Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2020English

Mediation Analysis Reveals Common Mechanisms of RUNX1 Point Mutations and RUNX1/RUNX1T1 Fusions Influencing Survival of Patients With Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2018English

Efficiency of Blinatumomab in a T(8;21) Acute Myeloid Leukemia Expressing CD19

Haematologica
Hematology
2019English

Novel Therapies for Children With Acute Myeloid Leukaemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Slow Relapse in Acute Myeloid Leukemia With Inv(16) or T(16;16)

Haematologica
Hematology
2009English

T(6;9)(p23;q34.1) Acute Myeloid Leukaemia With Cup-Like Blasts

British Journal of Haematology
Hematology
2018English

High Expression of RUNX1 Is Associated With Poorer Outcomes in Cytogenetically Normal Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy